IL-31 Antikörper
-
- Target Alle IL-31 (IL31) Antikörper anzeigen
- IL-31 (IL31) (Interleukin 31 (IL31))
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL-31 Antikörper ist unkonjugiert
-
Applikation
- Biochemical Assay (BCA)
- Aufreinigung
- The antibody was purified by affinity chromatography.
- Klon
- 1D10B31
- Isotyp
- IgG2b kappa
- Top Product
- Discover our top product IL31 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 0.5 mg/mL
- Buffer
- Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C
- Informationen zur Lagerung
- The antibody solution should be stored undiluted between 2°C and 8°C.
-
- Target
- IL-31 (IL31) (Interleukin 31 (IL31))
- Andere Bezeichnung
- IL-31 (IL31 Produkte)
- Synonyme
- IL-31 antikoerper, 1700013B14Rik antikoerper, IL31 antikoerper, interleukin 31 antikoerper, IL31 antikoerper, Il31 antikoerper
- Hintergrund
- IL-31, produced mainly by activated CD4+ T cells, is a newly discovered helical cytokine belonging to the gp130/IL6 cytokine family. IL-31 is closely related in structure to IL-6, IL-11, and IL-27. Binding of IL-31 to its receptor activates JAK/STAT, PI3K/AKT, and MAPK pathways. IL-31 acts on a broad range of immune and non-immune cells and thus possesses potential pleiotropic physiological functions, such as regulating hematopoiesis and immune response. Human IL-31 is also involved in inflammatory bowel disease, airway hypersensitivity, and dermatitis.
-